Trial Profile
A double-blind, crossover intranasal human abuse potential study of OXAYDO® (oxycodone)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 28 Sep 2016 New trial record